Mannkind (MNKD) Stock: Buy, Sell, or Hold?
$4.19
-0.04 (-0.95%)
▼
5d:
+6.62%
30d:
+37.38%
90d:
+12.33%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 05, 2026
0d
Protect MNKD Gains
Updated Nov 11, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (27%)
Quality Score
37/100
Position
EXTENDED
30-Day Fair Range
$3.10 – $3.85
Position: EXTENDED
Forward P/E & Valuation
26.6x
FAIR
vs 25.2x historical avg
Wall Street Target
$8.33
+98.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.45 / $4.29
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: MNKD shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When MNKD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: MNKD is currently trading at $4.19, which is considered extended relative to its 30-day fair value range of $3.10 to $3.85. The stock's valuation (Forward PE: 26.6) is in line with its historical norms (25.2). At these levels, the market is pricing in 1.8% annual earnings growth.
Technical Outlook: Technically, MNKD is in a downtrend. The price is approaching resistance at $4.29. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MNKD scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.33 (+98.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MNKD is in a downtrend. The price is approaching resistance at $4.29. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MNKD scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.33 (+98.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.10 -
$3.85
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
27.1%
Trading Range & Key Levels
30-Day Trading Range
$3.10 -
$3.85
Current vs Trading Range
EXTENDED
Support Level
$3.45
Resistance Level
$4.29
Current Trend
Downtrend
Technical data as of
Nov 11, 2026
Protect Your Profits
Holding MNKD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range (+8.8% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 98.9% below Wall St target ($8.33)
- BULLISH: Expecting earnings turnaround to 1.8% growth with 24.0% revenue growth
- WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
26.60
Wall Street Target
$8.33
(+98.9%)
Revenue Growth (YoY)
24.0%
Earnings Growth (YoY)
-34.9%
Profit Margin
-18.1%
Valuation Premium vs History
+1.8% premium
PE vs Historical
26.6 vs 25.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.8%
(market-implied from PE analysis)
1-Year Target
$4.27
(+2%)
2-Year Target
$4.34
(+4%)
3-Year Target
$4.42
(+6%)
3-Yr Target (if PE normalizes)
(PE: 27→25)
PE COMPRESSION
$4.19
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 26.6, Growth: 950.0%)
$14.14
(+238%)
Base:
(SPY PE: 19.9, Growth: 950.0%)
$10.56
(+152%)
Bear:
(PE: 16.9, Growth: 950.0%)
$8.97
(+114%)
Share MNKD Analysis
Share this live MNKD analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (MNKD)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
Bullish sentiment prevails on StockTwits for $MNKD with no recent news articles available.
Key Retail Themes:
Bullish sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:10 PM ET
Data refreshes hourly during market hours. Next update: 9:10 PM
Data refreshes hourly during market hours. Next update: 9:10 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MNKD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$978 | 35 SELL |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
21 analysts |
$650 | 38 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$296 | 31 SELL |
|
NAMS
NewAmsterdam Pharma Comp… |
STRONG BUY
16 analysts |
$50 | 44 HOLD |
|
IMUX
Immunic Inc |
STRONG BUY
13 analysts |
$43 | 51 HOLD |
Advanced MNKD Option Strategies
Professional options setups generated by AI based on today's MNKD price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive MNKD Research Pages